Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.74% | 185.45 | 0.0% | $900.62m | |
| AMGN | Amgen, Inc. | -1.11% | 243.52 | 1.5% | $585.46m | |
| NVAX | Novavax, Inc. | 0.63% | 60.65 | 75.7% | $464.73m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.19% | 291.47 | 1.9% | $424.89m | |
| GILD | Gilead Sciences, Inc. | -0.80% | 60.60 | 1.0% | $369.30m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.14% | 614.44 | 2.6% | $344.92m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.00% | 3.87 | 0.7% | $270.53m | |
| ILMN | Illumina, Inc. | 1.05% | 226.12 | 3.3% | $244.07m | |
| BIIB | Biogen, Inc. | -0.84% | 216.36 | 1.8% | $199.53m | |
| GOVX | GeoVax Labs, Inc. | 2.48% | 3.30 | 0.0% | $164.40m | |
| BNTX | BioNTech SE | -8.80% | 167.00 | 0.0% | $139.82m | |
| CRSP | CRISPR Therapeutics AG | -1.63% | 80.07 | 0.6% | $130.60m | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 7.56% | 21.77 | 0.0% | $98.19m | |
| MRTX | Mirati Therapeutics, Inc. | 3.99% | 90.01 | 1.6% | $97.25m | |
| APDN | Applied DNA Sciences, Inc. | 3.26% | 6.02 | 9.0% | $97.10m |
Company Profile
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.